Royal Gold Inc. (RGLD) is Trading Lower on Unusual Volume for January 11

Equities Staff |

Royal Gold Inc. (RGLD) experienced unusually high volume on Jan. 11, as the stock lost 10.93% to a closing price of $33.48. The stock saw 1.27 million shares trade hands over the course of the day on 10,993 trades. Given that the stock’s average daily volume over the last month has been 769,154 shares a day, this represents a pretty substantial spike over the norm.

Royal Gold Inc. has a P/B ratio of 0.95. The stock has traded between $77.20 and $34.42 over the last 52-weeks, its 50-day SMA is now $37.91, and its 200-day SMA $51.65.

Royal Gold Inc together with its subsidiaries is engaged in acquiring and managing precious metals royalties, precious metals streams and similar interests.

Headquartered in Denver, CO, Royal Gold Inc. has 20 employees and is currently under the leadership of CEO Tony Jensen.

For a complete fundamental analysis analysis of Royal Gold Inc., check out’s Stock Valuation Analysis report for RGLD. To see the latest independent stock recommendations from’s analysts, visit our Research section.


The Russell 3000 is not well known outside the world of finance, but it’s one of the strongest indices out there for getting a broad sense of the stock market. Unlike the better-known Dow Jones Industrial Average or S&P 500, membership on the Russell 3000 isn’t selected by committee. It’s simply the 3,000 most valuable companies in the country.

With 3,000 stocks making up the index, it gives a broad look at the markets, including the small-and mid-cap companies that aren’t on the Dow or the S&P 500. And with a rules-based system for determining membership, there’s no bias that could potentially limit membership. That’s why many financial professionals will turn to the Russell 3000 long before the better-known indices when trying to take the temperature of the market.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Emerging Growth

Kiwa Bio-Tech Products Group Corp

Kiwa Bio-Tech Products Group Corp develops, manufactures, distributes and markets, cost-effective and environmentally safe bio-technological products for agriculture in China.

Private Markets


Snapchat is the fastest way to share a moment with friends. The mobile app, allows users to not only share photos with friends but also control how long they can…

BioSculpture Technology, Inc.

BioSculpture Technology, Inc. (“BST”) is a commercial-stage medical device manufacturer of liposuction surgical instruments for surgeons. It offers the FDA-cleared Twin Cannula Assisted Liposuction ("TCAL") Airbrush Liposculptor II® controllers, Airbrush®…